Interestingly, in accordance with that, analysis of the TCGA-PRAD database showed that PLXND1 overexpression is significantly associated with a poor disease-free survival in PCa, suggesting that EDCs could participate in cancer aggressiveness (and metastasis) through this new signaling pathway. Here, PLXND1 is linked to prostate adenocarcinoma.